Biotech | April 28, 2022
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
When a critical patient is en-route to the hospital and every second makes a difference, the 5G Connected ambulance acts as an extension of the emergency room
Nocria’s hand-held device uses gentle, controlled puffs of air in the ears for treating migraine attacks
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)
The approval comes soon after Corbevax was given the nod for 12-15-year group
Covaxin was earlier approved for children 12-18 years of age
Subscribe To Our Newsletter & Stay Updated
